AROA BIOSURGERY LIMITED — Director's Dealing 2021

Jun 10, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Philip McCaw
Date of last notice	27 July 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

be disclosed in this part.
Direct or indirect interest		Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		Phil McCaw A/C> (Beneficiary)
Date of change		11 June 2021
No. of securities held prior to change		Indirect McSyth Capital Investment Trust of which he is a trustee and beneficiary (a) 16,722,425 Fully Paid Ordinary Shares (b) 245,775 Options exercisable at AU$0.75 expiring 23 July 2025
Class		(a) Fully Paid Ordinary Shares (b) Options exercisable at $0.75 expiring 23 July 2025
Number acquired		(a) 81,925
Number disposed		(b) 81,925
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		AU$61,443.75

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Indirect McSyth Capital Investment Trust of which he is a trustee and beneficiary 16,804,350 Fully Paid Ordinary Share 163,850 Options exercisable at $0.75 expiring 23 July 2025 Nature of change Exercise of options Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	-
Nature of interest	-
Name of registered holder	-
(if issued securities)
Date of change	-
No. and class of securities to	-
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired	-
Interest disposed	-
Value/Consideration	-
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change	-

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts	No
detailed above traded during a+closed period where
prior written clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date	N/A
was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011